Media Humiliated: Demo of Elon's Tech Proves They're Wrong

It's smaller than a quarter, but it could power Elon Musk's next AI revolution... A revolution he believes will be worth more than $9 trillion. Believe it or not, this device could even help put an extra $30k in your pocket every year outside of the markets.

A promising schizophrenia drug showed mixed results. What does that mean for patients?

CARLA K. JOHNSON
October 31, 2024

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday.

The results underscore the difficulties in treating schizophrenia, a severe mental illness that can cause people to hear voices, feel paranoid and withdraw from others. High dropout rates are typical in schizophrenia drug studies.

Finding a drug that works can be a long ordeal punctuated by crises and hospitalizations. Side effects of existing medications -- weight gain, tremors, restlessness -- cause some people to stop taking medicine and relapse.

There's been great hope among doctors for Cobenfy, which was approved in September, because it acts in the brain differently than other schizophrenia drugs. Instead of blocking dopamine receptors, Cobenfy's main ingredient, xanomeline, works on a different receptor that indirectly blocks dopamine release.

Cobenfy also contains trospium, which blocks some of the side effects. The most common are nausea, vomiting and indigestion. In contrast to the weight gain seen with other schizophrenia drugs, people lost a few pounds while taking Cobenfy, made by Bristol Myers Squibb.

Dr. John Krystal of Yale University has led research on other schizophrenia drugs but was not involved in the new studies. He noted that just 10% to 20% of participants in the new studies dropped out because of side effects.

"That is pretty good," he said, noting that fewer or milder side effects could mean people will stay in treatment longer. That could mean fewer problems associated with untreated mental illness: substance use, homelessness and unemployment.

So why did some patients stick with treatment while others dropped out? Krystal said it will be important to understand more about that as doctors start prescribing the drug.

The Food and Drug Administration approved Cobenfy on the strength of two encouraging company-sponsored five-week trials. The latest results announced Thursday at the Psych Congress meeting in Boston come from two longer studies, providing a fuller picture.

In one study, focused on severely ill patients, 78% dropped out, leaving only 35 people for the final analysis. In the other, focused on more stable people, 51% left the study, leaving 283 who took the drug for a year.

"It's not any higher or any lower than what we typically see" in schizophrenia studies, said Dr. Greg Mattingly of Washington University School of Medicine in St. Louis. Mattingly is a consultant for Bristol Myers Squibb and a researcher on one of the studies.

In the more severely ill group, 69% of people had a meaningful improvement in their symptoms at the end of the year. In the other group, 30% saw a meaningful benefit.

Results of interviews with a sample of study participants conducted by an independent research team and shared by Bristol Myers Squibb showed the likelihood of continuing treatment. After six months, 36 said they would continue taking Cobenfy after the trial if given the option; 10 said they would not. Some participants said the drug reduced the voices while others said it didn't work for them.

The estimated yearly cost for Cobenfy is $22,500 compared to $540 for a generic antipsychotic. Krystal and others worry that insurers will require people to try cheaper drugs first before covering Cobenfy.

One cheaper generic called clozapine is widely considered one of the best treatments for schizophrenia, Krystal said. It is underused in the U.S. compared to some other countries because of a cumbersome blood testing program.

The FDA started the blood tests to watch for the risk of severe neutropenia, a rare side effect which can be fatal. But doctors and families have told the FDA that patients have relapsed when their clozapine was withheld or delayed because of the testing requirements.

Sally Littlefield, 29, of Alameda, California, said what works for her is a monthly injection of a long-acting antipsychotic medication. Littlefield, who has schizophrenia and bipolar disorder, wants to learn more about the experiences of people who've taken Cobenfy and not just from players with a financial stake.

Mindy Greiling of Roseville, Minnesota, wants to see data on how Cobenfy compares to clozapine, which works for her 47-year-old son, Jim. Weight gain was a problem for him, but since taking diabetes medication, he's back to his normal weight, Greiling said.

Cobenfy "is getting a lot of ballyhoo, as any new drug does," Greiling said. "It's just a nonstarter for me unless it turns out that it's better than clozapine."

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group. The AP is solely responsible for all content.

Continue Reading...

Popular

Warren Buffett Says Parents Should Do This One Thing Before They Die, Whether They Are Rich Or Not

Legendary investor Warren Buffett has a piece of critical advice for parents that he believes they should follow, regardless of their wealth status.

44 years after New York couple vanished, car matching description of theirs is found in Georgia

BRUNSWICK, Georgia (AP) — A car similar to one driven by a wealthy New York couple missing for more than four decades has been found in a south Georgia pond near the hotel where they were last seen, police in Georgia said.

Single Stock Blueprint Available Now - Ad

Market Wizard Larry Benedict is one of the most successful traders you'll ever meet...But he doesn't make money the traditional way. In short: It's a way to trade just one stock...And potentially make all the money you need to fast-track your retirement -- no matter what happens in the stock market.

Stocks to Buy (and Sell) Before Inauguration Day

Experts predict Trump's policies will positively affect energy, finance, defense sectors; stocks to buy include EPD, JPM, LMT, while others may decline.

Tesla Cybertruck Crash In California Claims 3 Lives, Leaves 1 Seriously Injured

In a tragic incident early Wednesday, a Tesla Cybertruck crashed in Piedmont, California, resulting in three fatalities and one serious injury.

Is NVDA a Sell? Buy This Stock Instead Before Dec. 31 - Ad

After soaring over 150% in 2024 alone... is it actually time to buy Nvidia? A 50-year Wall Street veteran gives his answer to Nvidia, right here... Including the name and ticker of one under-the-radar AI stock to buy instead of Nvidia... before Tuesday, December 31st.

UPS to pay $45M to US settle charges that it improperly valued its freight division

UPS will pay $45 million to settle charges that it improperly valued its freight division, the Securities and Exchange Commission announced Friday.

Financial and community hurdles slow geothermal energy development in Southeast Asia

JAKARTA, Indonesia (AP) — Providing round-the-clock energy, using minimal space and considered a clean source of power — geothermal energy seems like an ideal option for countries like Indonesia and the Philippines, where the potential is high, and governments are seeking to transition away from highly polluting fossil fuels.

Donald Trump Can't Save You From This Crisis - Ad

A huge economic crisis is about to strike America. 12 months from today, our country could be unrecognizable. That's why I've recorded this video and released it for free. Inside, I lay out exactly what's happening and several critical moves I believe every American should make right now.

Radical Jaguar rebrand and new logo sparks ire online

NEW YORK (AP) — A for a rebrand of British luxury car brand Jaguar is being criticized online for showing models in brightly colored outfits — and no car.

Features Delay In iOS 19, Tim Cook's Trump Strategy, And Airpods Pro 2's Hearing Aid Feature: This Week In Appleverse

From potential delays in key iOS 19 features to the company's Black Friday deals, there's a lot to unpack. Let's dive into the top five stories that have kept Apple in the headlines.

Has the Tech Stock Selloff Finally Arrived? - Ad

After soaring over 150% in 2024 alone... is it actually time to buy Nvidia? A 50-year Wall Street veteran gives his answer to Nvidia, right here...Including the name and ticker of one under-the-radar AI stock to buy instead of Nvidia... before Tuesday, December 3rd.

Zuckerberg dines with Trump in Mar-a-Lago

FORT LAUDERDALE, Fla. (AP) — Donald Trump dined on Wednesday with Meta CEO at the president-elect’s Mar-a-Lago club in Florida, bringing together the Facebook founder and the former president who was once banned from that social network.

Joe Biden Pardons Hunter -- Donald Trump Likely To Pardon January 6 Protestors, Polymarket Traders Speculate

Trump may pardon January 6th rioters, Hunter Biden, Edward Snowden, Julian Assange, and Steve Bannon, showcasing his views on justice and loyalty.

Forget Nvidia, Apple, Tesla, and Google - Ad

Market Wizard Larry Benedict: "Forget 99% of stocks: It's possible to make all the money you need for a happy retirement with just this one."

Are MicroStrategy's Shares Worth Only $105? Investment Adviser Gary Black Weighs In

Renowned investment adviser Gary Black questioned the valuation of MicroStrategy Incorporated, suggesting the company's stock was significantly overpriced.

Economist Slams DOGE: Tells Elon Musk-Led Initiative To 'Do Your Legal Job Well' Amid Super Bowl Ad Spending Clash

Prominent economist Claudia Sahm has criticized the newly formed Department of Government Efficiency (DOGE) and its leadership’s approach to government spending, particularl

Media Humiliated: Demo of Elon's Tech Proves They're Wrong - Ad

It's smaller than a quarter, but it could power Elon Musk's next AI revolution... A revolution he believes will be worth more than $9 trillion. Believe it or not, this device could even help put an extra $30k in your pocket every year outside of the markets.

Ethereum ETF With Integrated Staking To Be Approved In The Future: Bernstein

Ethereum (CRYPTO: ETH) ETFs could soon offer staking yields, marking a significant evolution in institutional crypto investment, according to a new Bernstein report.

Will Mark Cuban Join Rivals Elon Musk, Vivek Ramaswamy's DOGE? 'Shark Tank' Host Says 'Both Know How To Reach Me'

Mark Cuban has expressed willingness to collaborate with Elon Musk and Vivek Ramaswamy's Department of Government Efficiency (DOGE) by offering his Cost Plus Drug Company to help cut federal healthcare costs through its transparent and affordable pricing model.

Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad

This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.

From yuck to profits: Some Zimbabwe farmers turn to maggots to survive drought and thrive

NYANGAMBE, Zimbabwe (AP) — At first, the suggestion to try farming maggots spooked Mari Choumumba and other farmers in Nyangambe, a region in southeastern Zimbabwe where wiped out the staple crop of corn.

He'll be the last meatpacker in the Meatpacking District. Here's how NYC's gritty 'hood got chic

NEW YORK (AP) — When John Jobbagy’s grandfather immigrated from Budapest in 1900, he joined a throng of European butchers chopping up and shipping off meat in a loud, smelly corner of Manhattan that New Yorkers called the Meatpacking District.

My TOP Altcoin for Right Now Is... - Ad

Searching for the top investment opportunity in crypto? Look no further. Our $3 report gives you the full scoop. You'll get this exciting token's name, our recommended investment strategy, and growth projections. Time is of the essence with this one...

Students can now apply for federal college aid. Officials hope for a smoother rollout this year

WASHINGTON (AP) — The federal FAFSA form used to apply for college financial aid opened to high school seniors nationwide on Thursday, a year after a by the Biden administration delayed the application for months.

Nebraska's Two-Front War On Cannabis

Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.

Is a Starlink IPO Coming in 2024? - Ad

Could there be signs that a Starlink IPO is set for the second half of 2024? According to one top venture capitalist, the answer is YES! And for the first time ever, you have the rare chance to profit pre-IPO... BEFORE Starlink goes public.

Canada Prepares Retaliatory Tariffs After Trump Threats: Analysts Warn Of Further Loonie Weakness

Canada prepares for potential tariffs on US goods following Trump's threats. Discussions underway to target certain items if tariffs are enacted.

Watch Jeff's New Demo: Elon Musk's New $9 Trillion AI Product - Ad

Why is Jeff Brown blindfolded and with his hands tied behind his back? It's all part of a crazy experiment involving a Cybertruck. See this demo because if Jeff is right... Elon Musk could make a lot of people rich with his new AI technology.

The UK will consult on sales targets for automakers during the transition to electric vehicles

LONDON (AP) — Britain’s new Labour government will launch a consultation on auto manufacturers' sales targets during the transition to electric vehicles, following the decision by Stellantis, the owner of Vauxhall, to close its van factory in southern England at the potential cost of 1,100 jobs.

Archegos hedge fund founder Bill Hwang gets 18 years in prison for massive fraud

NEW YORK (AP) — The founder of Archegos Capital Management, a hedge fund, was sentenced to 18 years in prison on Wednesday for securities and market manipulation fraud in a scheme that prosecutors said cost global investment banks billions of dollars.

Trump: The Bitcoin President - Ad

Bitcoin surged past $100,000, driven by Trump's plan to make the U.S. the "Bitcoin Superpower." While most investors are buying Bitcoin, I've uncovered a $25 "Bitcoin loophole" that's set to deliver potential gains of 6,865% -- without needing to own any coins or ETFs.

Elon Musk Agrees That People Want To See Jeffrey Epstein Files

Billionaire Elon Musk on Saturday shared a post on X  which said "The people want the Diddy & Epstein Files." Later he shared his perspective by saying "Yes" on the post.

Australian Senate begins debate on world-first social media ban for children under 16

MELBOURNE, Australia (AP) — The Australian Senate on Thursday began considering a from social media after the House of Representatives overwhelmingly supported the age restriction.

Huge Tesla Pivot Changes Everything - Ad

Elon Musk's new plan for Tesla's future has nothing to do with electric cars...TechRadar reports it "will blow your mind..." & McKinsey says it "will shape the coming decade." We recently got our hands on a video clip detailing this breakthrough.

SoftBank Secures Bigger OpenAI Stake With $1.5B Employee Share Buyout: Report

OpenAI is enabling employees to sell up to $1.5 billion worth of shares in a tender offer led by SoftBank

What's Going On With AMD Stock?

Advanced Micro Devices shares are trading higher by 2.1% during Monday's session. The U.S. imposed its latest round of semiconductor export restrictions on China.

Is This Defi Coin Your Next "10-Bagger" Investment? - Ad

Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.

What to know about Lori Chavez-DeRemer, Trump's pick for labor secretary

WASHINGTON (AP) — on Friday named Oregon Rep. Lori Chavez-DeRemer to lead the Department of Labor in , elevating a Republican congresswoman who has strong support from unions in her district but lost reelection in November.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service